3 pathways of increased potassium
potassium excess due to altered metabolism or intake
extracellular shift due to acidosis, insulin deficiency or drugs
extracellular release due to pathological cell lysis
When K+ shifts out of the cell, it’s a BAD LOSS!
Beta blockers, Acidosis, Digoxin, Lysis, hyperOsmolality, high Sugar, Succinylcholine
causes of accumulating potassium excess
reduced excretion eg. CKD
endocrine causes eg. hypocorticolism, hypoaldosteronism
drugs eg. potassium sparing diuretics, ACE inhibitors, ARBs, NSAIDs
increased intake
K+ containing IV fluids
causes of extracellular shift of potassium
acidosis
hyperosmolality
insulin deficiency
drugs: beta blockers, succinylcholine, digoxin
causes of extracellular release of potassium
pathological cell lysis eg. rhabdomyolysis, TLS, haemolysis
high blood cell turnover eg. thrombocytosis, erythrocytosis, leukocytosis
pseudohyperkalaemia
what is pseudohyperkalaemia
iatrogenic blood cell lysis
eg.
blood drawn from the side of IV infusion or a central line without previous flushing
prolonged use of a tourniquet
fist clenching during blood withdrawal
delayed sample analysis
clinical features of hyperkalaemia
Cardiac arrhythmias (e.g., atrioventricular block, ventricular fibrillation)
Muscle weakness, paralysis, paresthesia
↓ Deep tendon reflexes
Nausea, vomiting, diarrhoea
why does hyperkalaemia cause ↓ Deep tendon reflexes
While a reduced resting potential initially increases membrane excitability, persistent depolarization eventually inactivates sodium channels and leads to reduced total membrane excitability.
what effect does high potassium have on resting membrane potentials
An increased extracellular potassium concentration decreases the resting potential gradient, leading to a reduced voltage. This brings the membrane potential closer to the threshold that triggers an action potential. Persistent depolarization eventually inactivates sodium channels, which ultimately reduces the net membrane excitability.
approach to hyperkalaemic emergency
continuous cardiac monitoring
nephrology and critical care consults
admit to hospital for ongoing monitoring and treatment
repeat serum K at 1, 2, 4, 6 and 24 hours after treatment, patients whose potassium remains high will require for frequent monitoring
what kind of insulin/glucose to administer
rule out hypoglycaemia first
short-acting insulin 10 units IV bolus
PLUS EITHER
glucose 50% 50 mL IV over 5 minutes (can cause vascular irritation when administered peripherally)
OR
glucose 10% 250 mL IV over 15 minutes.
what is the reasoning for administering calcium gluconate
calcium gluconate 0.22 mmol/mL 2.2 mmol (10 mL) IV over 2 to 3 minutes into a large vein. Monitor response by ECG if possible
for life threatening cardiac arrhythmias or severe ECg changes.
the effect of this infusion is short lived. the dose may need to be repeated in 30-60 minutes, while undertaking specific measures to reduce potassium
what are some oral potassium binders
Calcium polystyrene sulfonate.
Patiromer (Veltassa®).
Sodium polystyrene sulfonate (Kionex®).
Sodium zirconium cyclosilicate (Lokelma®).
To remember K+-lowering treatments, think C BIG K Die (if you see a big serum K+, your patient may die!):
Calcium salts, Beta-agonists/Bicarbonate, Insulin + Glucose, Kation exchange medication, Dialysis/Diuretics.
calcium salts reduce
cardiac irritability
Calcium reduces the threshold potential of cardiac cells and restores the normal gradient with the resting membrane potential.
Calcium salts should result in normalization of the ECG appearance within 5 minutes; observe the cardiac monitor following initial treatment and repeat the dose if the ECG tracing still appears abnormal.
when hyperkalaemia is due to adrenal insufficiency, how should this change the management
When hyperkalaemia is due to adrenal insufficiency, corticosteroid replacement is the main treatment. Insulin should be avoided.